Clinical Trials

Ongoing clinical trials in molecular imaging and radiotheranostics. Sorted by date of last update.

Title	Phase	Last Update
Lu-177-DOTA-EB-TATE in Adult Patients with Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer Phase 1 Last update: April 27	Phase 1	April 27
PSMA-High: EBRT/ PSMA617/ ADT vs. EBRT/ ADT Phase 2 Last update: April 24	Phase 2	April 24
Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma Phase 2 Last update: April 24	Phase 2	April 24
Phase I Study of [Lu-177]Lu-NNS309 in Patients with Pancreatic, Lung, Breast and Colorectal Cancers Phase 1 Last update: April 24	Phase 1	April 24
Open-Label Study of Pocenbrodib Alone and in Combination with Abiraterone Acetate, Olaparib, or Lu-177-PSMA-617 (P300) Phase 1 Last update: April 24	Phase 1	April 24
A Study of Lu-177-FAP-2286 in Advanced Solid Tumors (LuMIERE) Phase 1 Last update: April 23	Phase 1	April 23
A Phase Ib/II Open-label Study of AMO959 with Lutetium (Lu-177) Vipivotide Tetraxetan (AAA617) in Combination with ARPI in Adult Participants with PSMA-positive mCRPC Phase 1 Last update: April 23	Phase 1	April 23
Low-Count Quantitative SPECT for Men Treated with Radium-223 N/A Last update: April 23	N/A	April 23
Y-90 with Durvalumab/Gem/Cis in Intrahepatic Cholangio Phase 2 Last update: April 22	Phase 2	April 22
Testing Lutetium Lu-177 Dotatate in Patients with Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors Phase 2 Last update: April 22	Phase 2	April 22